Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC648761 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZMYM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GPR78 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBLN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NEFL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RHAG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UGT1A6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TOR2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAGE5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ODF3L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGLJ3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLDN18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102724165 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRPV2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100505912 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARNT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRPS1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on